LumiraDx Submits SARS-COV-2 & Flu A/B Rapid Antigen Test for FDA EUA
LumiraDx has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the FDA for Emergency Use Authorization (EUA).
Read MorePosted by Chris Wolski | Oct 15, 2021 | Covid 19, Flu & Respiratory Infections |
LumiraDx has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the FDA for Emergency Use Authorization (EUA).
Read MorePosted by Chris Wolski | Oct 13, 2021 | Sepsis |
Prenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Read MorePosted by Chris Wolski | Oct 13, 2021 | Covid 19, Immunoassay Reagents & test Kits |
In a newly released document, analysis from the FDA questions the sensitivity of a test used by Johnson & Johnson to make a case for COVID-19 booster shots.
Read MorePosted by Chris Wolski | Oct 12, 2021 | Company News |
Quest Diagnostics Incorporated has completed its integration of Northeast regional operations to its new lab facility in Clifton, N.J.
Read MorePosted by Toni Mitchell | Oct 12, 2021 | Covid 19 |
A team of scientists and doctors from Singapore has developed the capability to detect airborne SARS-CoV-2 RNA through indoor air sampling.
Read More